The use of prostaglandins and antiprogestins for pregnancy termination (Q38349318)

2 September 2017

1 reference

title

The use of prostaglandins and antiprogestins for pregnancy termination (English)

1 reference

2 September 2017

M Bygdeman

1 reference

2 September 2017

P F Van Look

series ordinal

1 reference

2 September 2017

publication date

1 May 1989

1 reference

International Journal of Gynecology and Obstetrics

2 September 2017

published in

1 reference

2 September 2017

1 reference

2 September 2017

1 reference

2 September 2017

page(s)

5-12

1 reference

Progesterone receptor blockage. Effect on uterine contractility and early pregnancy.

2 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2F0020-7292%2889%2990121-5

Termination of early pregnancy by the 3 beta-hydroxysteroid dehydrogenase inhibitor epostane.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0020-7292%2889%2990121-5

The prospects of PGs in postconceptional therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0020-7292%2889%2990121-5

Treatment with a single vaginal suppository containing 15-methyl PGF2α methyl ester at expected time of menstruation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0020-7292%2889%2990121-5

Termination of early human pregnancy with epostane

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0020-7292%2889%2990121-5

Therapeutic abortion in early pregnancy with antiprogestogen RU486 alone or in combination with prostaglandin analogue (gemeprost)

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0020-7292%2889%2990121-5

Termination of very early pregnancy by RU 486--an antiprogestational compound

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0020-7292%2889%2990121-5

Termination of early gestation with the anti-progestin steroid RU 486: medium versus low dose

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0020-7292%2889%2990121-5

Induction of therapeutic abortion in early pregnancy with mifepristone in combination with prostaglandin pessary

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0020-7292%2889%2990121-5

Randomized comparison of prostaglandin treatment in hospital or at home with vacuum aspiration for termination of early pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0020-7292%2889%2990121-5

The effect of the antiprogestin RU 486 on uterine contractility and sensitivity to prostaglandin and oxytocin

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0020-7292%2889%2990121-5

Uses of RU 486 for contragestion: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0020-7292%2889%2990121-5

Myometrial activity in first trimester human pregnancy after Epostane therapy. Effect of intravenous oxytocin

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0020-7292%2889%2990121-5

Interruption of first trimester human pregnancy following Epostane therapy. Effect of prostaglandin E2 pessaries

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0020-7292%2889%2990121-5

Menstrual regulation by intramuscular injections of 16-phenoxy-tetranor PGE2 methyl sulfonylamide or vacuum aspiration. A randomized multicentre study. World Health Organization Task Force on Post-ovulatory Methods for Fertility Regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0020-7292%2889%2990121-5

10.1016/0020-7292(89)90121-5

21 January 2018

Identifiers

DOI

1 reference

2 September 2017

1 reference